Unichem Pharmaceuticals (usa), Inc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Unichem Pharmaceuticals (usa), Inc Pharmaceutical Import Records from India — 12 Products, $141.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unichem Pharmaceuticals (usa), Inc — Pharmaceutical Importer Profile (2026) | 12 Products, $141.6M Trade | TransData Nexus

Import Portfolio — Top 12 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Iron	Vitamins & Supplements	$26.1M	561	3.1%	2
2	Amlodipine	Cardiovascular	$22.6M	483	0.2%	2
3	Allopurinol	Lipid & Metabolism	$19.7M	412	0.5%	1
4	Hydrochlorothiazide	Diuretics	$19.1M	409	0.5%	1
5	Montelukast	Respiratory	$11.9M	239	3.3%	4
6	Bisoprolol	Cardiovascular	$8.8M	201	1.1%	1
7	Metronidazole	Advanced Antibiotics	$7.8M	173	2.6%	2
8	Meloxicam	Analgesics & Antipyretics	$7.8M	181	1.0%	1
9	Sodium	Nutritional Supplements	$7.0M	140	1.9%	5
10	Amiodarone	Cardiovascular	$5.0M	102	3.0%	1
11	Atenolol	Cardiovascular	$4.4M	232	5.2%	3
12	Tramadol	Analgesics & Antipyretics	$1.4M	28	0.4%	15

Unichem Pharmaceuticals (usa), Inc imports 12 pharmaceutical products across 8 categories into United States totaling $141.6M. The company is the #1 buyer for 5 products: Allopurinol, Hydrochlorothiazide, Bisoprolol, Meloxicam, Amiodarone.

Unichem Pharmaceuticals (usa), Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Unichem Pharmaceuticals (USA), Inc. is a privately held pharmaceutical company headquartered in East Brunswick, New Jersey. Established in 2005, it serves as the U.S. subsidiary of Unichem Laboratories Limited, an India-based developer and manufacturer of generic prescription drugs. The company specializes in marketing and distributing its own label generic pharmaceutical products across the United States, focusing on providing quality and cost-effective medications with reliable customer service.

Unichem Pharmaceuticals (USA) operates as a pharmaceutical importer and distributor, sourcing finished pharmaceutical formulations from India. Its product portfolio spans 12 products across eight therapeutic categories, including cardiovascular, vitamins & supplements, and lipid & metabolism. The company has established itself as a significant player in the U.S. pharmaceutical distribution network, leveraging its parent company's manufacturing capabilities to offer a diverse range of FDA-approved generic drugs.

2Distribution Network

Unichem Pharmaceuticals (USA) maintains its primary distribution center in East Brunswick, New Jersey. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic positioning in New Jersey provides advantageous access to major U.S. markets. This location facilitates efficient distribution and timely delivery of pharmaceutical products throughout the United States.

3Industry Role

In the U.S. pharmaceutical supply chain, Unichem Pharmaceuticals (USA) functions as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from India, the company plays a crucial role in introducing generic medications to the U.S. market. Its operations bridge the gap between international manufacturers and U.S. consumers, ensuring the availability of cost-effective and quality pharmaceutical products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Unichem Pharmaceuticals (usa), Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unichem Pharmaceuticals (USA) exhibits a high degree of sourcing concentration, importing 70.2% of its products from India. This significant reliance on a single source indicates a strategic choice to leverage the manufacturing capabilities and cost advantages offered by Indian pharmaceutical producers. The company's substantial import value of $141.6 million USD and 3,161 shipments from India underscore the stability and strength of this sourcing relationship.

The concentration on Indian suppliers suggests a well-established and stable relationship, likely characterized by long-term contracts and consistent product quality. However, this dependency also exposes Unichem Pharmaceuticals (USA) to potential risks associated with geopolitical factors, regulatory changes, and supply chain disruptions in India. Diversifying the supplier base could mitigate such risks and enhance supply chain resilience.

2Supply Chain Resilience

Unichem Pharmaceuticals (USA) relies heavily on its Indian supply chain, importing a significant majority of its products from India. While the company benefits from cost-effective manufacturing and a robust product pipeline, this heavy reliance may pose challenges in terms of supply chain resilience. Potential risks include geopolitical instability, regulatory changes, and logistical disruptions in India. To enhance resilience, Unichem Pharmaceuticals (USA) could consider diversifying its supplier base and establishing relationships with manufacturers in other regions.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The Federal Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework governing these activities, ensuring that drugs imported into the U.S. are safe, effective, and properly labeled. The FDA's Regulatory Procedures Manual Chapter 9 outlines the import operations and actions required for compliance.

For Indian pharmaceutical exporters, understanding and adhering to FDA regulations is crucial. This includes ensuring that products meet FDA standards for quality, safety, and effectiveness, as well as complying with labeling requirements. The FDA reviews shipments of imported drugs to determine their admissibility into the U.S., and products may be refused entry if they are found to be adulterated, misbranded, or unapproved.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. All foreign drug establishments whose products are imported into the U.S. are required to register their establishment with the FDA and list all their drug products in commercial distribution in the United States. This process ensures that imported drugs meet FDA standards for quality, safety, and effectiveness.

Unichem Pharmaceuticals (usa), Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unichem Pharmaceuticals (USA) focuses on importing generic pharmaceutical products across various therapeutic areas, including cardiovascular, vitamins & supplements, and lipid & metabolism. This strategic focus aligns with market demand for affordable and effective medications in these categories. The company's portfolio concentration, with the top five products accounting for 70.2% of imports, indicates a targeted approach to meet specific patient needs and market demands.

2Sourcing Profile

Unichem Pharmaceuticals (USA) employs a sourcing strategy that heavily relies on Indian pharmaceutical manufacturers, importing finished pharmaceutical formulations rather than raw active pharmaceutical ingredients (APIs). This approach allows the company to leverage India's manufacturing capabilities and cost advantages while ensuring compliance with FDA regulations for finished dosage forms. The company's focus on finished formulations aligns with its goal of providing quality and cost-effective products to the U.S. market.

3Market Positioning

Based on its product mix, Unichem Pharmaceuticals (USA) serves various segments of the U.S. pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's diverse therapeutic portfolio enables it to address a wide range of patient needs, positioning it as a versatile supplier in the U.S. pharmaceutical distribution network.

Seller's Guide — How to Become a Supplier to Unichem Pharmaceuticals (usa), Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Unichem Pharmaceuticals (USA), especially if they can offer high-quality, FDA-compliant finished pharmaceutical formulations. Gaps in Unichem Pharmaceuticals (USA)'s current sourcing may include specific therapeutic areas or product forms not currently covered. New suppliers can explore these areas to meet unmet market needs and strengthen their position in the U.S. market.

2Requirements & Qualifications

Indian exporters seeking to supply Unichem Pharmaceuticals (USA) and the U.S. market must ensure that their products comply with FDA regulations, including registration and listing requirements. Obtaining GMP certifications recognized by the FDA, such as those from the EU, WHO, or PIC/S, is essential. Additionally, products must meet

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Unichem Pharmaceuticals (usa), Inc

What products does Unichem Pharmaceuticals (usa), Inc import from India?

Unichem Pharmaceuticals (usa), Inc imports 12 pharmaceutical products across 8 categories. Top imports: Iron ($26.1M), Amlodipine ($22.6M), Allopurinol ($19.7M), Hydrochlorothiazide ($19.1M), Montelukast ($11.9M).

What is Unichem Pharmaceuticals (usa), Inc's total pharmaceutical import value?

Unichem Pharmaceuticals (usa), Inc's total pharmaceutical import value from India is $141.6M, based on 3,161 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Unichem Pharmaceuticals (usa), Inc focus on?

Unichem Pharmaceuticals (usa), Inc imports across 8 categories. The largest: Cardiovascular (28.8%), Vitamins & Supplements (18.4%), Lipid & Metabolism (13.9%).

Get Full Unichem Pharmaceuticals (usa), Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 6 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Unichem Pharmaceuticals (usa), Inc

Unichem Pharmaceuticals (usa), Inc — Import Portfolio & Supplier Network

What Products Does Unichem Pharmaceuticals (usa), Inc Import?

Top Products by Import Value

Unichem Pharmaceuticals (usa), Inc Therapeutic Categories — 8 Specializations